C3a and C5a stimulate chemotaxis of human mast cells

Blood

Volumn 89, Issue 8, 1997, Pages 2863-2870

  Hartmann, Karin ^a   Henz, Beate M ^b   Krüger Krasagakes, Sabine ^b   Köhl, Jörg ^b   Burger, Reinhard ^b   Gurtl, Sven ^b   Haase, Ingo ^b   Lippert, Undine ^b   Zuberbier, Torsten ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHEMOTACTIC FACTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 3; LAMININ; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; NERVE GROWTH FACTOR; PERTUSSIS TOXIN; RANTES; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CALCIUM CELL LEVEL; CELL ADHESION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPERSENSITIVITY; INFLAMMATION; MAST CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

EID: 0030893717     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.8.2863     Document Type: Article

References (60)

1. Weber S, Krüger-Krasagakes S, Grabbe J, Zuberbier T, Czarnetzki BM: Mast cells. Int J Dermatol 34:1, 1995
2. Thompson HL, Burbelo PD, Yamada Y, Kleinman HK, Metcalfe DD: Mast cells chemotax to laminin with enhancement after IgE-mediated activation. J Immunol 143:4188, 1989
3. Matsuura N, Zetter BR: Stimulation of mast cell chemotaxis by interleukin 3. J Exp Med 170:1421, 1989
4. Jippo-Kanemoto T, Adachi S, Ebi Y, Matsuda H, Kasugai T, Nishikawa S, Kitamura Y: BALB/3T3 fibroblast-conditioned medium attracts cultured mast cells derived from W/W but not from mi/mi mutant mice, both of which are deficient in mast cells. Blood 80:1933, 1992
5. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR: The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 79:958, 1992
6. Gruber BL, Marchese MJ, Kew RR: Transforming growth factor-β1 mediates mast cell chemotaxis. J Immunol 152:5860, 1994
7. Taub D, Dastych J, Inamura N, Upton J, Kelvin D, Metcalfe D, Oppenheim J: Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J Immunol 154:2393, 1995
8. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A: Stem cell factor is a chemotactic factor for human mast cells. J Immunol 153:3717, 1994
9. Burger R, Zilow G: Complement-derived anaphylatoxins in natural immunity, in Sim E (ed): The Natural Immune System: Humoral Factors. New York, NY, Oxford, 1993, p 209
10. Köhl J, Bitter-Suermann D: Anaphylatoxins, in Whaley K, Loos M, Weiler JM (eds): Complement in Health and Disease, vol 20. Dordrecht, The Netherlands, Kluwer Academic, 1993, p 299
11. Van der Linden PWG, Hack CE, Kerckhaert JAM, Struyvenberg A, Van der Zwan JC: Preliminary report: Complement activation in wasp-sting anaphylaxis. Lancet 336:904, 1990
12. Stöve S, Weite T, Wagner TOF, Kola A, Klos A, Bautsch W, Köhl J: Circulating complement proteins in patients with sepsis or SIRS. Clin Diag Lab Immunol 3:175, 1996
13. Dias da Silva W, Lepow IH: Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement. J Exp Med 125:921, 1967
14. Meuer S, Ecker U, Hadding U, Bitter-Suermann D: Plateletserotonin release by C3a and C5a: Two independent pathways of activation. J Immunol 126:1506, 1981
15. + suppressor T cell. J Immunol 134:51, 1985
16. Morgan EL, Thoman ML, Weigle WO, Hugli TE: Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses. J Immunol 130:1257, 1983
17. Swerlick RA, Yancey KB, Lawley TJ: A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin. J Immunol 140:2376, 1988
18. Yancey KB, Hammer CH, Harvath L, Renfer L, Frank MM, Lawley TJ: Studies of human C5a as a mediator of inflammation in normal human skin. J Clin Invest 75:486, 1985
19. Lepow IH, Willms-Kretschmer K, Patrick RA, Rosen FS: Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man. Am J Pathol 61:13, 1970
20. Fernandez HN, Henson PM, Otani A, Hugli TE: Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions. J Immunol 120:109, 1978
21. Morita E, Schröder JM, Christophers E: Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. Scand J Immunol 29:709, 1989
22. Daffern PJ, Pfeifer PH, Ember JA, Hugli TE: C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 181:2119, 1995
23. Bischoff SC, De Weck AL, Dahinden CA: Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc Natl Acad Sci USA 87:6813, 1990
24. Schulman ES, Post TJ, Henson PM, Giclas PC: Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. J Clin Invest 81:918, 1988
25. Patella V, Marinò I, Lampärter B, Arbustini E, Adt M, Marone G: Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J Immunol 154:2855, 1995
26. El-Lati SG, Dahinden CA, Church MK: Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 102:803, 1994
27. Johnson AR, Hugli TE, Müller-Eberhard HJ: Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology 28:1067, 1975
28. 2-terminal domain. J Immunol 151:3785, 1993
29. Kretzschmar T, Pohl M, Casaretto M, Przewosny M, Bautsch W, Klos A, Saunders D, Kohl J: Synthetic peptides as antagonists of the anaphylatoxin C3a. Eur J Biochem 210:185, 1992
30. Burger R, Bader A, Kirschfink M, Rother U, Schrod L, Wörner I, Zilow G: Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody. Clin Exp Immunol 68:703, 1987
31. Bautsch W, Emde M, Kretzschmar T, Köhl J, Suckau D, Bitter-Suermann D: Human C5a anaphylatoxin: Gene cloning and expression in Escherichia coli. Immunobiology 185:41, 1992
32. Klos A, Ihrig V, Messner M, Grabbe J, Bitter-Suermann D: Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies. J Immunol Methods 111:241, 1988
33. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12:345, 1988
34. Mitsui H, Furitsu T, Dvorak AM, Irani AMA, Schwartz LB, Inagaki N, Takei M, Ishizaka K, Zsebo KM, Gillis S, Ishizaka T: Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci USA 90:735, 1993
35. Dvorak AM, Furitsu T, Kissell-Rainville S, Ishizaka T: Ultrastructural identification of human mast cells resembling skin mast cells stimulated to develop in long-term human cord blood mononuclear cells cultured with 3T3 murine skin fibroblasts. J Leukoc Biol 51:557, 1992
36. Benyon RC, Lowman MA, Church MK: Human skin mast cells: Their dispersion, purification, and secretory characterization. J Immunol 138:861, 1987
37. Krüger-Krasagakes S, Grützkau A, Baghramian R, Henz BM: Interactions of immature human mast cells with extracellular matrix: Expression of specific adhesion receptors and their role in cell binding to matrix proteins. J Invest Dermatol 106:538, 1996
38. Landegren U: Measurement of cell numbers by means of the endogenous enzyme hexosaminidase: Applications to detection of lymphokines and cell surface antigens. J Immunol Methods 67:379, 1984
39. Leavesley DI, Schwartz MA, Rosenfeld M, Cheresh DA: Integrin β1- and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 121:163, 1993
40. Gaudry M, Caon AC, Gilbert C, Lille S, Naccache PH: Evidence for involvement of tyrosine kinases in the locomotory responses of human neutrophils. J Leukoc Biol 51:103, 1992
41. Gerard NP, Gerard C: The chemotactic receptor for human C5a anaphylatoxin. Nature 349:614, 1991
42. Gerard NP, Hodges MK, Drazen JM, Weller PF, Gerard C: Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem 264:1760, 1989
43. Füreder W, Agis H, Willheim M, Bankl HC, Maier U, Kishi K, Müller MR, Czerwenka K, Radaszkiewicz T, Butterfield JH, Klappacher GW, Sperr WR, Oppermann M, Lechner K, Valent P: Differential expression of complement receptors on human basophils and mast cells: Evidence for mast cell heterogeneity and CD88/ C5aR expression on skin mast cells. J Immunol 155:3152, 1995
44. Hartung HP, Bitter-Suermann D, Hadding U: Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77. J Immunol 130:1345, 1983
45. Kretzschmar T, Jeromin A, Gietz C, Bautsch W, Klos A, Köhl J, Rechkemmer G, Bitter-Suermann D: Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a. Eur J Immunol 23:558, 1993
46. Mousli M, Hugli TE, Landry Y, Bronner C: A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J Immunol 148:2456, 1992
47. Nilsson G, Blom T, Kusche-Gullberg M, Kjellen L, Butterfield JH, Sundström C, Nilsson K, Hellman L: Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol 39:489, 1994
48. Grabbe J, Welker P, Möller A, Dippel E, Ashman LK, Czarnetzki BM: Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). J Invest Dermatol 103:504, 1994
49. Selvan RS, Butterfield JH, Krangel MS: Expression of multiple chemokine genes by a human mast cell leukemia. J Biol Chem 269:13893, 1994
50. Werfel T, Oppermann M, Butterfield JH, Begemann G, Elsner J, Götze O, Zwirner J: The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg). Scand J Immunol 44:30, 1996
51. Hartmann K, Beiglböck F, Czarnetzki BM, Zuberbier T: Effect of CC chemokines on mediator release from human skin mast cells and basophils. Int Arch Allergy Immunol 108:224, 1995
52. Fukuoka Y, Hugli TE: Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control. J Immunol 145:1851, 1990
53. Gruber BL, Marchese MJ, Kew R: Angiogenic factors stimulate mast-cell migration. Blood 86:2488, 1995
54. Ghebrehiwet B, Kew RR, Gruber BL, Marchese MJ, Peerschke EIB, Reid KBM: Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis. J Immunol 155:2614, 1995
55. Füreder W, Agis H, Semper H, Keil F, Maier U, Müller MR, Czerwenka K, Höfler H, Lechner K, Valent P: Differential response of human basophils and mast cells to recombinant chemokines. Ann Hematol 70:251, 1995
56. Takaishi T, Morita Y, Hirai K, Yamaguchi M, Ohta K, Noda E, Morita T, Ito K, Miyamoto T: Effect of cytokines on mediator release from human dispersed lung mast cells. Allergy 49:837, 1994
57. Columbo M, Bochner BS, Marone G: Human skin mast cells express functional β1 integrins that mediate adhesion to extracellular matrrix proteins. J Immunol 154:6058, 1995
58. + bone marrow progenitor cells. J Immunol 146:1410, 1991
59. Legler DF, Loetscher M, Jones SA, Dahinden CA, Arock M, Moser B: Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. Eur J Immunol 26:753, 1996
60. Nilsson G, Johnell M, Hammer CH, Tiffany HL, Nilsson K, Metcalfe DD, Siegbahn A, Murphy PM: C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157:1693, 1996